Some bronchoalveolar lavage parameters and leukocyte cytokine release in response to intratracheal instillation of short and long asbestos and wollastonite fibres in rats

Physiological Research

Volumn 46, Issue 6, 1997, Pages 459-466

  Hurbankova M ^a   Kaiglova A ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Amosite; Cytokines; Fibre size; Lavage parameters; Wollastonite

Indexed keywords

ACID PHOSPHATASE; AMOSITE; ASBESTOS FIBER; CYTOKINE; GAMMA INTERFERON; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASBESTOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IMMUNE RESPONSE; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NONHUMAN; OCCUPATIONAL LUNG DISEASE; PHAGOCYTOSIS; RAT;

ANIMALS; ASBESTOS, AMOSITE; BRONCHOALVEOLAR LAVAGE FLUID; CALCIUM COMPOUNDS; CARCINOGENS; FEMALE; INTERFERON TYPE II; LEUKOCYTES; MACROPHAGES, ALVEOLAR; RATS; RATS, WISTAR; SILICATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031457122     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BRAIN J.D.: Mechanisms, measurement, and significance of lung macrophage function. Environ. Health Perspect. 97: 5-10, 1992.
2. BRODY A.R.: Asbestos-induced lung diseases. Environ. Health Perspect. 100: 21-30, 1993.
3. BUCHANCOVÁ J., ŽIGOVÁ A., PLANK L., VRLÍK M., GÁLIKOVÁ E.: Occupational exposure to a carcinogen and tumors of the respiratory system. Stud. Pneumol. Phtiseol. Czech 48: 516-521, 1988.
4. CARRE P., LEOPHONTE P.: Cytokines and pulmonary fibroses. Rev. Mal. Respir. 10: 193-207, 1993.
5. DAVIS J.M.G., BOLTON R.E., DONALDSON, K., JONES A.D., SMITH T.: The pathogenicity of long versus short fibres of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br. J. Exp. Pathol. 67: 415-430, 1986.
6. DODSON R.F., FORD J.O.: Tissue reaction following a second exposure to amosite asbestos. Cytobios 68: 53-62, 1991.
7. DONALDSON K., BOLTON R.E., JONES A., BROWN G.M., ROBERTSON M.D., SLIGHT J., COWIE H., DAVIS J.H.: Kinetics of the bronchoalveolar leukocyte response in rats during exposure to equal airborne mass concentrations of quartz, chrysotile asbestos, or titanium dioxide. Thorax 43: 525-533, 1988.
8. DZIEDZIC D., WHEELER C.S., GROSS K.B.: Bronchoalveolar lavage: detecting markers of lung injury. In: Handbook of Hazardous Materials. Morton, Academic Press, San Diego, 1993, pp. 99-111.
9. FERENCIK M.: Immunochemistry. Alfa, Bratislava, 1989, pp. 452-530,
10. FORNUSEK L., VETVICKA V., KOPECEK J.: Phagocytosis of the peritoneal leukocytes a new single method. Immunol. zpravodaj 13: 67-68, 1982.
11. GOMBOS B., BOBRO M., SIROKOVÁ K., ULRICH L.: Risk of chrysotile asbestos. Cs. hyg. 37: 93-99, 1992.
12. HURBÁNKOVÁ M.: One-year follow-up of the phagocytic activity of leukocytes after exposure of rats to asbestos and basalt fibres. Environ. Health Perspect. 102 (Suppl. 5): 201-203, 1992.
13. HURBÁNKOVÁ M., KAIGLOVÁ A.: The changes of some immunological parameters in subjects exposed to asbestos in dependence on age, duration of exposure, radiological findings and smoking habits. Zbl. Hyg. 95: 55-65, 1993.
14. HURBÁNKOVÁ M., ULRICH L.: Untersuchung einiger immunologischer Merkmale bei professioneller Asbestexposition und bei anderen Mineralfasern. Zbl. Hyg. 193: 130-139, 1992.
15. JAURAND M.C.: Particulate state carcinogenesis: a survey of recent studies on the mechanisms of fibres. IARC Sci. Publ. 90: 54-73, 1989.
16. LARRICK W., KUNKEL S.L.: The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharmaceut. Res. 5: 219-139, 1988.
17. LI X.Y, LAMB D., DONALDSON K.: Intratracheal injection of crocidolite asbestos depresses the secretion of tumor necrosis factor by pleural leukocytes in vitro. Exp. Lung Res. 18: 359-372, 1992.
18. MCCLELLAN R.O., HESTERBERG T.W.: Role of biopersistence in the pathogenicity of man-made fibres and methods for evaluating biopersistence: a summary of two round-table discussions. Environ. Health Perspect. 102 (Suppl. 5): 277-283, 1994.
19. MOHR U., POTT F., VONNAHNE F.J.: Morphological aspects of mesotheliomas after intratracheal instillations of fibrous dusts in Syrian golden hamsters. Exp. Pathol. 26: 179-183, 1984.
20. MORINAGA K.: Asbestos-related diseases. Asian Med. J. 36: 413-422, 1993.
21. MOSSMAN B.T, JASSEN Y.M., MARSH J.P., SESKOA., SHATOS M.A., DOHERTY J., ADLER K.D., HEMENWAY D., MICKEY R., VACEK V.: Development and characterization of a rapid-onset rodent inhalation model of asbestosis for disease prevention. Toxicol. Pathol. 19: 412-418, 1991.
22. MURRAY M.: Charing Cross Hospital Gazette, 1900.
23. MYRVIK Q.N., LEAKE E.S., FARISS, B.: Studies on pulmonary alveolar macrophages from the normal rabbit. A technique to procedure them in a high state of purity. J. Immunol. 86: 128-132, 1961.
24. NAVRÁTIL M., DOBIÁŠ J.: Development of pleural hyalinosis in long term studies, in persons exposed to asbestos dust. Environ. Res. 6: 455-472, 1973.
25. NOUZA K., JOHN C.: Immunology in Health and Disease. Praha, Avicenum, 1987.
26. OGHISO Y., YAMADA Y., SHIBATA Y.: Effects of instilled fibrogenic particles on the clonal growth of murine pulmonary alveolar macrophages. Environ. Health Prospect. 97: 159-161, 1992.
27. PETO J., SEIDMAN H., SELIKOFF I.J.: Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br. J. Cancer 45: 124-135, 1982.
28. PETRUSKA J.M., LESLIE K.O., MOSSMAN B.T.: Enhanced lipid peroxidation in lung lavage of rats after inhalation of asbestos. Free Radic. Biol. Med. 11: 425-432, 1991.
29. POTT F., ZIEM U., REIFFER F.J., HUTH F., ERNST M., MOHR U.: Carcinogenicity studies an fibres, metal components, and some other dusts in rats. Exp. Pathol. 32: 129-152, 1987.
30. QUELLET S., YANG H.X., AUDIR R.A., HAWLEY R.G., WENKEBACH G.F.C., LEMAIRE I.: Bidirectional modulation of TNF-α production by alveolar macrophages in asbestos-induced pulmonary fibrosis. J. Leukocyte Biol. 53: 279-286, 1993.
31. ROM W.N.: Relationship of inflammatory cell cytokines to disease severity in individuals with occupational inorganic dust exposure. Am. J. Ind. Med. 19: 15-27, 1991.
32. SCHWARTZ D.A., GALVIN J.R., FREES K.L., DAYTON C.S., BURMEISTER L.F., MERCHANT J.A., HUNNINGHAKE G.W.: Clinical relevance of cellular mediators of inflammation in workers exposed to asbestos. Am. Rev. Respir. Dis. 148: 68-74, 1993.
33. STANTON M.F., LAYARD M., TEGERIS A., MILLER E., MAY M., MORGAN E., SMITH, A.: Relation of particle dimension to carcinogenicity in amosite asbestos and other fibrous minerals. J. Natl. Cancer Inst. 67: 965-975, 1981.
34. TARKOWSKI M., GORSKI P.: Macrophage activity in asbestos related diseases. Polish J. Occup. Med. Environ. Health 4: 115-125, 1991.
35. TILKES F., BECK E.G.: Macrophage functions after exposure to mineral fibres. Environ. Health Perspect. 51: 67-72, 1983.
36. VIALLAT J.R., RAYBUAD F., PASSAREL M., BOUTIN C.: Pleural migration of chrysotile fibres after intratracheal injection in rats. Arch. Environ. Health 41: 282-286, 1986.
37. ZHANG Y., LEE T.C., GUILLEMIN B., YU M.C., ROM, W.N.: Enhanced IL-1 β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150: 4188-96, 1993.